NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/03/2024
Back to search
Official data from USPTO
AICON-BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AICON-BIO
ST13
US500000097805951Class
1, 5, 9
Filing
97805951
Registration
7497098
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
09/03/2024
Trademark type
Word
Nice classes
1, 5, 9
Filing date
02/22/2023
Registration date
09/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/03/2024
Last transaction
09/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/01/2023
First use in commerce
11/01/2023
Drawing code
4
Owner type
03
Owner location
Tigard, OR, US
Examiner
FERRAIUOLO, DOMINIC
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Aicon Biotech Inc
Representatives
Aicon Biotech Inc
Technical classification
Nice Classes
Class 1Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical reagents commonly known as probesfor detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Cell culture reagents for scientific and research use; Diagnostic reagents for scientific or research use; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplificationanalysis or labeling of nucleic acid; Immunohistochemistry detection kits consisting of mouse secondary reagentsDAB chromogensDAB buffersperoxidase blocking reagenthematoxylinfor anatomic pathology purposes in the medical diagnostics industry
Class 5
Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Medical diagnostic reagents
Class 9
Laboratory consumablespipette tips
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/03/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/10/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/09/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/27/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/25/2024
IUAF
USE AMENDMENT FILED
03/05/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/05/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/26/2023
PUBO
PUBLISHED FOR OPPOSITION
12/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2023
DOCK
ASSIGNED TO EXAMINER
11/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/13/2023
NWAP
NEW APPLICATION ENTERED
02/25/2023
Continuous trademark protection
Get notified about every new filing that threatens AICON-BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.